AGP Executive Report
Last update: 9 hours agoRare Disease Support: Switzerland plans two new laws to boost help for people living with rare diseases, including funding for specialised care structures and information/advisory services, plus a national rare-disease register targeted for early 2030. Job Cuts in Pharma: Novartis will cut up to 130 jobs in Basel by end-2027 after ending small-scale biologics production in Kleinbasel, with work shifting to the Novartis campus across the Rhine. Cardiac Diagnostics: Researchers in Zurich and Greifswald validated the BioTAK score, a new way to spot Takotsubo syndrome earlier—before catheterisation—using a scoring system based on sex and blood biomarkers. Mental Health & Safety: Swiss police say the Aarau rave shooting was a “rampage” carried out by a lone 43-year-old suspect who turned himself in; prosecutors describe him as having psychological problems. Clinical Research: A trial reported enVast-assisted mechanical thrombectomy reduced infarct size in large-thrombus STEMI patients, adding to the evidence for thrombectomy approaches.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
